Fingerprint
Dive into the research topics of 'A phase 2 study of momelotinib, a potent JAK1 and JAK2 inhibitor, in patients with polycythemia vera or essential thrombocythemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Srdan Verstovsek, Stephane Courby, Martin Griesshammer, Ruben A. Mesa, Carrie Baker Brachmann, Jun Kawashima, Julia D. Maltzman, Lixin Shao, Yan Xin, Daniel Huang, Ashish Bajel
Research output: Contribution to journal › Article › peer-review